{"schema":"hottub-news/list/v1","item_schema":"hottub-news/item/v1","count":4,"sponsored":0,"items":[{"id":"n_vaz5uevn3ytl7cm3di5q","seq":1432986,"kind":"article","title":"Insider Selling: United Therapeutics (NASDAQ:UTHR) CEO Sells $5,476,465.00 in Stock","url":"https://www.dailypolitical.com/2026/10/02/insider-selling-united-therapeutics-nasdaquthr-ceo-sells-5476465-00-in-stock.html","published":"2026-10-02T21:21:21Z","seen":"2026-10-02T21:21:21Z","lang":"en","source":{"id":"dailypolitical.com","name":"dailypolitical.com","domain":"dailypolitical.com"},"via":"gdelt-gkg-english","topics":["economy","health"],"authors":["Latisha Jones"],"entities":[{"id":"Q21071142","name":"United Therapeutics","type":"org"},{"id":"Q484876","name":"chief executive officer","type":"person"}],"story":"st_vaz5uevn3ytl7cm3di5q","category":"economy-business","category_p":0.85,"sentiment":"neutral","tone":0.53,"political":0.27},{"id":"n_dvwnqnxbdyava2xffghq","seq":1357192,"kind":"article","title":"Head-To-Head Contrast: United Therapeutics (NASDAQ:UTHR) vs. Emergent Biosolutions (NYSE:EBS)","url":"https://www.themarketsdaily.com/2026/10/02/head-to-head-contrast-united-therapeutics-nasdaquthr-vs-emergent-biosolutions-nyseebs.html","published":"2026-10-02T13:52:51Z","seen":"2026-10-02T13:52:51Z","lang":"en","source":{"id":"themarketsdaily.com","name":"themarketsdaily.com","domain":"themarketsdaily.com"},"via":"gdelt-gkg-english","topics":["economy","business","health"],"authors":["Mitch Edgeman"],"entities":[{"id":"Q21071142","name":"United Therapeutics","type":"org"},{"id":"Q5370757","name":"Emergent BioSolutions","type":"org"}],"story":"st_dvwnqnxbdyava2xffghq","category":"economy-business","category_p":0.32,"category2":"health","sentiment":"neutral","tone":-0.01,"political":0.14},{"id":"n_5vsrohi433vbbxsn4nca","seq":1057008,"kind":"article","title":"United Therapeutics Prevails In Patent Litigation Against Liquidia","url":"https://www.rttnews.com/3695556/united-therapeutics-prevails-in-patent-litigation-against-liquidia.aspx","published":"2026-10-01T04:34:00Z","seen":"2026-10-01T05:10:03Z","lang":"en","source":{"id":"rttnews.com","name":"rttnews.com","domain":"rttnews.com","outlet":{"wikidata":"Q60748698","name":"RTTNews","type":"news_agency","designations":["news agency","news website"]}},"via":"gdelt-gkg-english","topics":["economy","health","business"],"entities":[{"id":"Q21071142","name":"United Therapeutics","type":"org"}],"story":"st_hbkc2xia5pwdehwg6jqa","category":"economy-business","category_p":0.32,"category2":"health","sentiment":"positive","tone":0.18,"political":0.06},{"id":"n_mzj2ets6p6wx5exgnx6q","seq":560263,"kind":"article","title":"United Therapeutics (UTHR): Goldman Says Sell As The Base Business Shrinks, But 2027 Holds Real Catalysts","url":"https://www.insidermonkey.com/news/united-therapeutics-uthr-goldman-says-sell-as-the-base-business-shrinks-but-2027-holds-real-catalysts-1845850","published":"2026-09-29T02:15:00Z","seen":"2026-09-29T02:20:13Z","lang":"en","source":{"id":"insidermonkey.com","name":"insidermonkey.com","domain":"insidermonkey.com"},"via":"gdelt-gkg-english","topics":["business","economy"],"authors":["Faheem Tahir"],"entities":[{"id":"Q21071142","name":"United Therapeutics","type":"org"},{"id":"Q1291546","name":"Edward Alphonso Goldman","type":"org"}],"story":"st_mzj2ets6p6wx5exgnx6q","category":"economy-business","category_p":0.94,"sentiment":"neutral","tone":0.01,"political":0.08}]}